Form 4 for TMCI TREACE MEDICAL CONCEPTS, INC.
Accepted 2024-05-22 00:00:00 ET · period of report 2024-05-21 · accession 0000950170-24-063616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-22 | 2024-05-21 | TMCI | Kiernan Jane E | Dir | A - Grant | $0.00 | +15.1K | 40.0K | +61% | $0 |
| D | 2024-05-22 | 2024-05-21 | TMCI | Kiernan Jane E | Dir | A - Grant | $0.00 | +33.3K | 33.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-21 | A | A | 15,091 | $0.00 | 40,032 | D | — | — | (F1) Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 21, 2025 or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. The Reporting Person voluntarily elected to defer receipt of the shares of the Issuer's Common Stock issuable upon settlement of the RSUs until the earlier of a change in control or the Reporting Person's separation of service to the Issuer. (F2) Includes 18,788 restricted stock units. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-05-21 | A | A | 33,260 | $0.00 | 33,260 | D | $4.97 · — to 2034-05-21 | 33,260 Common Stock | (F3) The stock option will vest in 12 substantially equal monthly installments, commencing on June 21, 2024, such that the stock option will be fully vested and exercisable on the earlier of (a) May 21, 2025, or (b) the date of the 2025 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through each vesting date. |